YIXINTANG PHARMACEUTICAL GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.86 CNY | +5.67% |
|
+3.27% | -9.93% |
| 04-26 | Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03-19 | Yixintang Pharmaceutical's Profit Falls 46% as Revenue Stays Nearly Flat | MT |
Evolution of the average Target Price on Yixintang Pharmaceutical Group Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
27767edec406a4.DbOdewGAQoclBg4nmXbKYV05WFbkiFfCRE6VxBn0HE0.X4OtIzDfMcoQM3gS91ueEBpWHwWc-BHyFXfHnSmxQ3hJ5K4hT9UhznJreQ~b3a7f2acc06e442bf97b62381ba66267
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
20.86
CNY
Average target price
24.16
CNY
Spread / Average Target
+15.81%
High Price Target
31
CNY
Spread / Highest target
+48.61%
Low Price Target
19.3
CNY
Spread / Lowest Target
-7.48%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Yixintang Pharmaceutical Group Co., Ltd.
| UBS |
Trading Rating
Investor Rating
ESG Refinitiv
C-
EPS Revisions
- Stock Market
- Equities
- 002727 Stock
- Consensus Yixintang Pharmaceutical Group Co., Ltd.
